Statins, which are 3-hydroxy-methylglutaryl CoA reductase inhibitors generally used as cholesterol-lowering drugs, are also reported to inhibit the activity of YAP1 in breast cancer [13]. The gene discussed is HMGCR; the disease is breast cancer.